Literature DB >> 28185122

Multidisciplinary Approach in the Treatment of Resistant Hypertension.

S A Potthoff1, O Vonend2,3.   

Abstract

With its high prevalence and the eminent number of undetected or poorly controlled patients, the management of arterial hypertension is still a challenging task. Uncontrolled blood pressure is the major adjustable risk factor for cardiovascular end organ damage for coronary heart disease, heart failure, stroke, and renal disease. Patients with resistant hypertension often need a multidisciplinary approach in order to control their blood pressure sustainably. In cooperation with hypertension specialists, the underlying cause for therapy resistance should be evaluated. Pseudohypertension, white coat hypertension, and non-adherence need to be addressed. The medication can often be optimized and simplified. Reducing the number of pills per day can enhance the drug-adherence remarkably. The multidisciplinary evaluation of secondary causes of hypertension includes an endocrinological work-up, ruling out relevant sleeping disorders, and renal diagnostics. If there are no causative treatments possible and pharmacological and non-pharmacological measurements are not sufficient to control the blood pressure, one has to consider multidisciplinary approaches bringing nurses, pharmacists, dieticians, physiotherapists, social workers, psychologists, and community health workers onboard. Utilizing various strategies might improve medication management, patient follow-up, adherence, and self-management. Interventional therapy such as renal renervation, baroreflex activation therapy, or carotid body modulation is the final option that can be discussed with interventional active colleagues. However, large randomized controlled trials proving a benefit of these interventional therapies are still missing. The use of these still experimental approaches should be restricted to randomized controlled trials accordingly.

Entities:  

Keywords:  Adherence to therapy; Interventional therapy; Resistant hypertension; Secondary hypertension

Mesh:

Substances:

Year:  2017        PMID: 28185122     DOI: 10.1007/s11906-017-0698-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

1.  Barbershops as hypertension detection, referral, and follow-up centers for black men.

Authors:  Paul L Hess; Jason S Reingold; Jennifer Jones; Melissa A Fellman; Premere Knowles; Joseph E Ravenell; Stacey Kim; Jamie Raju; Erica Ruger; Sharonda Clark; Chibuike Okoro; Ore Ogunji; Patricia Knowles; David Leonard; Ruth P Wilson; Robert W Haley; Keith C Ferdinand; Anne Freeman; Ronald G Victor
Journal:  Hypertension       Date:  2007-04-02       Impact factor: 10.190

2.  Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.

Authors:  Yehonatan Sharabi; Eldad Adler; Ari Shamis; Naomi Nussinovitch; Avinoam Markovitz; Ehud Grossman
Journal:  Am J Hypertens       Date:  2006-07       Impact factor: 2.689

Review 3.  Update on intervention versus medical therapy for atherosclerotic renal artery stenosis.

Authors:  Albeir Y Mousa; Ali F AbuRahma; Joseph Bozzay; Mike Broce; Mark Bates
Journal:  J Vasc Surg       Date:  2015-06       Impact factor: 4.268

4.  Unobserved automated office blood pressure measurement in the Systolic Blood Pressure Intervention Trial (SPRINT): systolic blood pressure treatment target remains below 140 mmHg.

Authors:  Sverre E Kjeldsen; Giuseppe Mancia
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2016-01-27

Review 5.  Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future.

Authors:  Joana Delgado Silva; Marco Costa; Bernard J Gersh; Lino Gonçalves
Journal:  J Am Soc Hypertens       Date:  2016-06-02

6.  Blood Pressure Measurement in the Post-SPRINT Era: A Canadian Perspective.

Authors:  Martin G Myers; Lyne Cloutier; Mark Gelfer; Raj S Padwal; Janusz Kaczorowski
Journal:  Hypertension       Date:  2016-05-16       Impact factor: 10.190

7.  Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis.

Authors:  Philip A Kalra; Haifeng Guo; Annamaria T Kausz; David T Gilbertson; Jiannong Liu; Shu-Cheng Chen; Areef Ishani; Allan J Collins; Robert N Foley
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

8.  Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial.

Authors:  Patricia J Elmer; Eva Obarzanek; William M Vollmer; Denise Simons-Morton; Victor J Stevens; Deborah Rohm Young; Pao-Hwa Lin; Catherine Champagne; David W Harsha; Laura P Svetkey; Jamy Ard; Phillip J Brantley; Michael A Proschan; Thomas P Erlinger; Lawrence J Appel
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

9.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

Review 10.  Hypertension.

Authors:  Neil R Poulter; Dorairaj Prabhakaran; Mark Caulfield
Journal:  Lancet       Date:  2015-03-29       Impact factor: 79.321

View more
  3 in total

1.  Effect of an emergency department education and empowerment intervention on uncontrolled hypertension in a predominately minority population: The AHEAD2 randomized clinical pilot trial.

Authors:  Heather Prendergast; Marina Del Rios; Ramon Durazo-Arvizu; Sandra Escobar-Schulz; Sara Heinert; Maya Jackson; Renee Petzel Gimbar; Martha Daviglus; Brenda Lara; Shaveta Khosla
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-03-02

Review 2.  Comprehensive Care Models for Cardiometabolic Disease.

Authors:  Cara Reiter-Brennan; Omar Dzaye; Dorothy Davis; Mike Blaha; Robert H Eckel
Journal:  Curr Cardiol Rep       Date:  2021-02-24       Impact factor: 2.931

3.  Development and implementation of blood pressure screening and referral guidelines for German community pharmacists.

Authors:  Martin Schulz; Nina Griese-Mammen; Pia M Schumacher; Dorothea Strauch; Leonard Freudewald; André Said; Ross T Tsuyuki; Ulrich Laufs; Ulrich Kintscher; Michael Böhm; Felix Mahfoud
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-30       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.